Alphadyne Asset Management LP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1535943 NEW YORK, NY

Position in NTLA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$130,533

New position

Shares Held

10,182

first reported quarter

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alphadyne Asset Management LP holds $5,118,929 across 5 Biotechnology names. NTLA ranks #4 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,922	$3,984,029
2	REGN	Regeneron Pharmaceuticals, Inc.	754	$582,570
3	INSM	INSMED Inc	2,119	$346,498
4	NTLA	Intellia Therapeutics, Inc. This page	10,182	$130,533
5	BBIO	BridgeBio Pharma, Inc.	1,014	$75,299

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$130,533	10,182	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.